zalcitabine has been researched along with Antibody Deficiency Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hill, DL; Hoover, EA; Mullins, JI; Perigo, NA; Quackenbush, SL; Strobel, JD; Zeidner, NS | 1 |
| de Noronha, F; Postie, L; Roneker, C; Tavares, L | 1 |
| Hill, DL; Hoover, EA; Mullins, JI; Perigo, NA; Strobel, JD; Zeidner, NS | 1 |
3 other study(ies) available for zalcitabine and Antibody Deficiency Syndrome
| Article | Year |
|---|---|
Feline leukemia virus-induced immunodeficiency syndrome in cats as a model for evaluation of antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Animals; Cats; Cell Line; Cytopathogenic Effect, Viral; Delayed-Action Preparations; Dideoxynucleosides; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Implants; Drug Therapy, Combination; Immunologic Deficiency Syndromes; Injections, Intravenous; Injections, Subcutaneous; Leukemia Virus, Feline; Leukemia, Experimental; Retroviridae Infections; Specific Pathogen-Free Organisms; Tetrahydrouridine; Viremia; Zalcitabine | 1989 |
Testing of nucleoside analogues in cats infected with feline leukemia virus: a model.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antibodies, Viral; Antiviral Agents; Cats; Cell Line; Didanosine; Dideoxyadenosine; Dideoxynucleosides; Disease Models, Animal; Drug Evaluation, Preclinical; Immunologic Deficiency Syndromes; Leukemia Virus, Feline; Leukemia, Experimental; Nucleosides; Specific Pathogen-Free Organisms; Virus Replication; Zalcitabine; Zidovudine | 1989 |
Treatment of FeLV-induced immunodeficiency syndrome (FeLV-FAIDS) with controlled release capsular implantation of 2',3'-dideoxycytidine.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antibodies, Monoclonal; Capsules; Cats; Dideoxynucleosides; Disease Models, Animal; Drug Implants; Drug Therapy, Combination; Gene Products, gag; Immunologic Deficiency Syndromes; Infusions, Intravenous; Injections, Subcutaneous; Interferon Type I; Leukemia Virus, Feline; Retroviridae Proteins; Tetrahydrouridine; Tumor Necrosis Factor-alpha; Virus Replication; Zalcitabine | 1989 |